177 related articles for article (PubMed ID: 21726186)
21. [Autologous transfusion - from euphoria to reason: clinical practice based on scientific knowledge. (Part IV). Artificial oxygen carriers: cell-free hemoglobin solutions -- current status 2004].
Standl T
Anasthesiol Intensivmed Notfallmed Schmerzther; 2005 Jan; 40(1):38-45. PubMed ID: 15645386
[TBL] [Abstract][Full Text] [Related]
22. Protection of endothelial function: targets for nutritional and pharmacological interventions.
Sudano I; Spieker LE; Hermann F; Flammer A; Corti R; Noll G; Lüscher TF
J Cardiovasc Pharmacol; 2006; 47 Suppl 2():S136-50; discussion S172-6. PubMed ID: 16794451
[TBL] [Abstract][Full Text] [Related]
23. The effects of hemoglobin glutamer-200 and iNO on pulmonary vascular tone and arterial oxygenation in an experimental acute respiratory distress syndrome.
Voelker MT; Bergmann A; Busch T; Jahn N; Laudi S; Noreikat K; Simon P; Bercker S
Pulm Pharmacol Ther; 2018 Apr; 49():130-133. PubMed ID: 29425776
[TBL] [Abstract][Full Text] [Related]
24. Endothelial dysfunction in hypertension.
Puddu P; Puddu GM; Zaca F; Muscari A
Acta Cardiol; 2000 Aug; 55(4):221-32. PubMed ID: 11041120
[TBL] [Abstract][Full Text] [Related]
25. Pediatric pulmonary hypertension: Roles of endothelin-1 and nitric oxide.
Black SM; Kumar S; Wiseman D; Ravi K; Wedgwood S; Ryzhov V; Fineman JR
Clin Hemorheol Microcirc; 2007; 37(1-2):111-20. PubMed ID: 17641401
[TBL] [Abstract][Full Text] [Related]
26. Haemoglobin-based erythrocyte transfusion substitutes.
Standl T
Expert Opin Biol Ther; 2001 Sep; 1(5):831-43. PubMed ID: 11728218
[TBL] [Abstract][Full Text] [Related]
27. HBOC-201, hemoglobin glutamer-250 (bovine), Hemopure (Biopure Corporation).
Jahr JS; Moallempour M; Lim JC
Expert Opin Biol Ther; 2008 Sep; 8(9):1425-33. PubMed ID: 18694360
[TBL] [Abstract][Full Text] [Related]
28. Exercise and the nitric oxide vasodilator system.
Maiorana A; O'Driscoll G; Taylor R; Green D
Sports Med; 2003; 33(14):1013-35. PubMed ID: 14599231
[TBL] [Abstract][Full Text] [Related]
29. Chronic therapy with isosorbide-5-mononitrate causes endothelial dysfunction, oxidative stress, and a marked increase in vascular endothelin-1 expression.
Oelze M; Knorr M; Kröller-Schön S; Kossmann S; Gottschlich A; Rümmler R; Schuff A; Daub S; Doppler C; Kleinert H; Gori T; Daiber A; Münzel T
Eur Heart J; 2013 Nov; 34(41):3206-16. PubMed ID: 22555214
[TBL] [Abstract][Full Text] [Related]
30. How Nitric Oxide Hindered the Search for Hemoglobin-Based Oxygen Carriers as Human Blood Substitutes.
Samaja M; Malavalli A; Vandegriff KD
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834350
[TBL] [Abstract][Full Text] [Related]
31. Roles of Vascular Oxidative Stress and Nitric Oxide in the Pathogenesis of Atherosclerosis.
Förstermann U; Xia N; Li H
Circ Res; 2017 Feb; 120(4):713-735. PubMed ID: 28209797
[TBL] [Abstract][Full Text] [Related]
32. Protective Effects of Glucagon-like Peptide 1 on Endothelial Function in Hypertension.
Liu L; Liu J; Huang Y
J Cardiovasc Pharmacol; 2015 May; 65(5):399-405. PubMed ID: 25384196
[TBL] [Abstract][Full Text] [Related]
33. Roles of oxidants, nitric oxide, and asymmetric dimethylarginine in endothelial function.
Siekmeier R; Grammer T; März W
J Cardiovasc Pharmacol Ther; 2008 Dec; 13(4):279-97. PubMed ID: 18945874
[TBL] [Abstract][Full Text] [Related]
34. Endothelin 1 type a receptor antagonism prevents vascular dysfunction and hypertension induced by 11beta-hydroxysteroid dehydrogenase inhibition: role of nitric oxide.
Ruschitzka F; Quaschning T; Noll G; deGottardi A; Rossier MF; Enseleit F; Hürlimann D; Lüscher TF; Shaw SG
Circulation; 2001 Jun; 103(25):3129-35. PubMed ID: 11425780
[TBL] [Abstract][Full Text] [Related]
35. Impairment and restoration of nitric oxide-dependent vasodilation in cardiovascular disease.
Lyons D
Int J Cardiol; 1997 Dec; 62 Suppl 2():S101-9. PubMed ID: 9488201
[TBL] [Abstract][Full Text] [Related]
36. The endothelium in coronary artery disease.
Ruschitzka FT; Noll G; Lüscher TF
Cardiology; 1997; 88 Suppl 3():3-19. PubMed ID: 9397288
[TBL] [Abstract][Full Text] [Related]
37. Biological response of human aortic endothelial cells exposed to acellular hemoglobin solutions developed as potential blood substitutes.
Toussaint-Hacquard M; Devaux Y; Longrois D; Faivre-Fiorina B; Muller S; Stoltz JF; Vigneron C; Menu P
Life Sci; 2003 Jan; 72(10):1143-57. PubMed ID: 12505545
[TBL] [Abstract][Full Text] [Related]
38. Endothelium-restricted overexpression of human endothelin-1 causes vascular remodeling and endothelial dysfunction.
Amiri F; Virdis A; Neves MF; Iglarz M; Seidah NG; Touyz RM; Reudelhuber TL; Schiffrin EL
Circulation; 2004 Oct; 110(15):2233-40. PubMed ID: 15466627
[TBL] [Abstract][Full Text] [Related]
39. Calcium channel blockers, endothelial dysfunction, and combination therapy.
Schulman IH; Zachariah M; Raij L
Aging Clin Exp Res; 2005 Aug; 17(4 Suppl):40-5. PubMed ID: 16640172
[TBL] [Abstract][Full Text] [Related]
40. Molecular mechanisms of endothelial dysfunction: from nitric oxide synthesis to ADMA inhibition.
Bermúdez V; Bermúdez F; Acosta G; Acosta A; Añez J; Andara C; Leal E; Cano C; Manuel V; Hernández R; Israili Z
Am J Ther; 2008; 15(4):326-33. PubMed ID: 18645335
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
